{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:37:05Z","timestamp":1787495825370,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018564","name":"Filkins Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018132","name":"Pennsylvania Lions Sight Conservation and Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ajo.2022.05.009","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T21:22:49Z","timestamp":1652822569000},"page":"36-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Cyclin D1 Expression and Molecular Genetic Findings in Periocular Histiocytoses and Neoplasms of Macrophage-Dendritic Cell Lineage"],"prefix":"10.1016","volume":"242","author":[{"given":"Tatyana","family":"Milman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Eiger-Moscovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-6409","authenticated-orcid":false,"given":"Roger K.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2768-2913","authenticated-orcid":false,"given":"Cristiane M.","family":"Ida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Ruben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3288-3632","authenticated-orcid":false,"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Lally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Penne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Stefanyszyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurij R.","family":"Bilyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-9522","authenticated-orcid":false,"given":"Christopher J.","family":"Rapuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Ralph C.","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.ajo.2022.05.009_bib0001","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ajo.2022.05.009_bib0002","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.ophtha.2015.06.009","article-title":"Juvenile xanthogranuloma involving the eye and ocular adnexa: tumor control, visual outcomes, and globe salvage in 30 patients","volume":"122","author":"Samara","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2022.05.009_bib0003","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2005.085894","article-title":"Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review","volume":"90","author":"Sivak-Callcott","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.05.009_bib0004","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.survophthal.2008.04.007","article-title":"Langerhans cell histiocytosis","volume":"53","author":"Margo","year":"2008","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.05.009_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/01676830.2016.1176211","article-title":"Erdheim-Chester disease with orbital involvement: case report and ophthalmic literature review","volume":"35","author":"Merritt","year":"2016","journal-title":"Orbit"},{"key":"10.1016\/j.ajo.2022.05.009_bib0006","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajo.2018.01.037","article-title":"Ophthalmic findings of Rosai-Dorfman disease","volume":"188","author":"Choi","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.05.009_bib0007","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.ajo.2022.05.009_bib0008","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","article-title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","volume":"131","author":"Abla","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ajo.2022.05.009_bib0009","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jclinpath-2020-206733","article-title":"Rosai-Dorfman disease: an overview","volume":"73","author":"Bruce-Brand","year":"2020","journal-title":"J Clin Pathol"},{"issue":"12","key":"10.1016\/j.ajo.2022.05.009_bib0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11926-019-0865-2","article-title":"Erdheim-Chester disease: a concise review","volume":"21","author":"Papo","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ajo.2022.05.009_bib0011","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/asheducation-2015.1.571","article-title":"Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease","volume":"2015","author":"Haroche","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ajo.2022.05.009_bib0012","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1182\/asheducation-2015.1.559","article-title":"Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders","volume":"2015","author":"Allen","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.ajo.2022.05.009_bib0013","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11912-019-0810-6","article-title":"Systemic histiocytosis (Langerhans cell histiocytosis, Erdheim-Chester disease, Destombes-Rosai-Dorfman disease): from oncogenic mutations to inflammatory disorders","volume":"21","author":"Papo","year":"2019","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.ajo.2022.05.009_bib0014","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s40478-019-0811-6","article-title":"BRAF V600E mutation in juvenile xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease","volume":"7","author":"Picarsic","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.ajo.2022.05.009_bib0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bjh.16006","article-title":"Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease","volume":"186","author":"Baraban","year":"2019","journal-title":"Br J Haematol"},{"issue":"28","key":"10.1016\/j.ajo.2022.05.009_bib0016","doi-asserted-by":"crossref","first-page":"46065","DOI":"10.18632\/oncotarget.17521","article-title":"Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ajo.2022.05.009_bib0017","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ajo.2022.05.009_bib0018","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1634\/theoncologist.2018-0295","article-title":"FDA approval summary: vemurafenib for the treatment of patients with Erdheim-Chester disease with the BRAFV600 mutation","volume":"23","author":"Oneal","year":"2018","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.ajo.2022.05.009_bib0019","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/onco.13541","article-title":"Efficacy of BRAF-inhibitor therapy in BRAF(V600E)-mutated adult Langerhans cell histiocytosis","volume":"25","author":"Hazim","year":"2020","journal-title":"Oncologist"},{"issue":"16","key":"10.1016\/j.ajo.2022.05.009_bib0020","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/bloodadvances.2018021782","article-title":"Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition","volume":"2","author":"Awada","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajo.2022.05.009_bib0021","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajoc.2018.07.005","article-title":"Orbital and chorioretinal manifestations of Erdheim-Chester disease treated with vemurafenib","volume":"11","author":"Huang","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajo.2022.05.009_bib0022","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajo.2017.01.017","article-title":"Three cases of Erdheim-Chester disease with intraocular manifestations: imaging and histopathology findings of a rare entity","volume":"176","author":"Tan","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"7749","key":"10.1016\/j.ajo.2022.05.009_bib0023","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","author":"Diamond","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ajo.2022.05.009_bib0024","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.3324\/haematol.2018.201194","article-title":"Highly sensitive methods are required to detect mutations in histiocytoses","volume":"104","author":"Melloul","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.ajo.2022.05.009_bib0025","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000000897","article-title":"Cyclin D1 is expressed in neoplastic cells of Langerhans cell histiocytosis but not reactive Langerhans cell proliferations","volume":"41","author":"Shanmugam","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ajo.2022.05.009_bib0026","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/PAS.0000000000000129","article-title":"BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases","volume":"38","author":"Roden","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ajo.2022.05.009_bib0027","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/modpathol.2017.160","article-title":"The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort","volume":"31","author":"Ozkaya","year":"2018","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.ajo.2022.05.009_bib0028","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/DAD.0000000000001250","article-title":"CyclinD1 is useful to differentiate Langerhans cell histiocytosis from reactive Langerhans cells","volume":"41","author":"Chatterjee","year":"2019","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.ajo.2022.05.009_bib0029","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/15321819.2020.1870132","article-title":"Cyclin D1: potential utility as marker for Langerhans cell histiocytosis","volume":"42","author":"Ben Rejeb","year":"2021","journal-title":"J Immunoassay Immunochem"},{"issue":"12","key":"10.1016\/j.ajo.2022.05.009_bib0030","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/DAD.0000000000002060","article-title":"Utility of cyclin D1 immunostaining in cutaneous xanthogranuloma","volume":"43","author":"Sharma","year":"2021","journal-title":"Am J Dermatopathol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422001994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422001994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:49:55Z","timestamp":1757598595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422001994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"alternative-id":["S0002939422001994"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.05.009","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclin D1 Expression and Molecular Genetic Findings in Periocular Histiocytoses and Neoplasms of Macrophage-Dendritic Cell Lineage","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}